Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
B
Benjamin J. Lieblong
Clinical Trial Coordinator
Also affiliated: Louisiana State University (2012); University of Arkansas Medical Center (2020); Moffitt Cancer Center (2012); Central Arkansas Veterans Healthcare System (2012); Charité - Universitätsmedizin Berlin (2012); Louisiana State University Health Sciences Center Shreveport (2012)
10 h-index
25 pubs
423 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Benjamin J. Lieblong's research focuses on the therapeutic treatment of cervical intraepithelial neoplasia (CIN). He has been involved in clinical trials investigating the efficacy of peptide-based human papillomavirus (HPV) therapeutic vaccines, such as PepCan, often in combination with adjuvants like Candida. His work includes evaluating treatment outcomes for CIN2/3 lesions, with a focus on immune responses, including the expansion of HPV-specific T cells. Lieblong has also contributed to studies examining cardiac inflammation following local irradiation, exploring its relationship with the kallikrein-kinin system. His scholarship metrics include an h-index of 10 with 25 publications and 408 citations. He has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Martin Hauer-Jensen and Vijayalakshmi Sridharan, with whom he shares multiple publications.
Metrics
- h-index: 10
- Publications: 25
- Citations: 423
Positions
-
Clinical Trial Coordinator 2016–presentUniversity of Arkansas for Medical Sciences Pathology ORCID
Selected Publications
-
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida (2025)
-
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)
-
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021)
-
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2020)
-
Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review (2020)
-
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer (2019)
-
Natural history of human papillomavirus and vaccinations in men: A literature review (2019)
-
Role of the bradykinin B2 receptor in a rat model of local heart irradiation (2015)
-
Dobutamine Stress Testing as an Early Diagnostic for Radiation‐Induced Heart Disease (2015)
-
Effects of radiation on the epidermal growth factor receptor pathway in the heart (2013)
-
Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System (2012)
Collaboration Network
Top Collaborators
Mayumi Nakagawa
University of Arkansas for Medical Sciences
7 shared publications
In database
- The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer
- Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review
- Natural history of human papillomavirus and vaccinations in men: A literature review
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
Showing 5 of 7 shared publications
Takeo Shibata
Kanazawa Medical University
5 shared publications
In database
- The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Sumit K. Shah
University of Arkansas for Medical Sciences
5 shared publications
In database
- Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Marjan Boerma
Moffitt Cancer Center
4 shared publications
In database
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Effects of radiation on the epidermal growth factor receptor pathway in the heart
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation
- Dobutamine Stress Testing as an Early Diagnostic for Radiation‐Induced Heart Disease
Teresa Evans
University of Arkansas for Medical Sciences
4 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Hannah Coleman
University of Arkansas for Medical Sciences
4 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Charles M. Quick
University of Arkansas for Medical Sciences
4 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Yong‐Chen Lu
University of Arkansas for Medical Sciences
4 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Vijayalakshmi Sridharan
Moffitt Cancer Center
3 shared publications
In database
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Effects of radiation on the epidermal growth factor receptor pathway in the heart
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation
Eduardo G. Moros
Moffitt Cancer Center (US)
3 shared publications
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Effects of radiation on the epidermal growth factor receptor pathway in the heart
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation
Toshiyuki Sasagawa
Kanazawa Medical University (JP)
3 shared publications
- The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Horace J. Spencer
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Sunil Sharma
Moffitt Cancer Center (US)
2 shared publications
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation
Peter M. Corry
Moffitt Cancer Center (US)
2 shared publications
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Effects of radiation on the epidermal growth factor receptor pathway in the heart
Preeti Tripathi
Moffitt Cancer Center (US)
2 shared publications
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Effects of radiation on the epidermal growth factor receptor pathway in the heart
Similar Researchers
Based on overlapping research topics
Neil Dogra
Hendrix College
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
Katherine Cruse
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
Ahmad Mazen Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
Teresa T. Evans
University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Amy Jones
University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research
Cancer Treatment and Pharmacology
Immune Response and Inflammation
William W. Greenfield
University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research
Cancer Treatment and Pharmacology
Immune Response and Inflammation